Current awareness updates
COVID-19 rapid guideline: managing COVID-19.
National Institute for Health and Care Excellence (NICE); 2021.
[In October, NICE added new recommendations on casirivimab and imdevimab. New data on the use of heparins (from the REMAP-CAP trial results) does not change the current recommendations.]
The consequences of COVID-19 lockdown for formal and informal resource utilization among home-dwelling people with dementia: results from the prospective PAN.DEM study.[Abstract]
Vislapuu M. BMC Health Services Research 2021;21(1):1003.
[The care situation for PwD changed dramatically in the early phase of the COVID-19 pandemic, especially for those living alone who received less support from homecare services and visiting caregivers. For future crises and the forthcoming post-pandemic period, health authorities must plan better and identify and prioritize those in greatest need.]
The impact of the COVID-19 pandemic on patterns of attendance at emergency departments in two large London hospitals: an observational study.[Abstract]
Vollmer MAC. BMC Health Services Research 2021;21(1):1008.
[Our study findings reflect broader trends seen across England and give an indication how emergency healthcare seeking has drastically changed. At ICHNT, we find that a larger proportion arrived by ambulance and that hospitalisation outcomes of patients without COVID-19 did not differ from previous years. The extent to which these findings relate to ED avoidance behaviours compared to having sought alternative emergency health services outside of hospital remains unknown.]
Remote schooling through the coronavirus (COVID-19) pandemic, England: April 2020 to June 2021.
Office for National Statistics (ONS); 2021.
[How remote learning has affected the amount of learning materials covered by pupils and the dependence of remote learning on parental input over the course of the coronavirus (COVID-19) pandemic.]
Inequalities in accessing dementia care and support during COVID-19.
The Mental Elf; 2021.
[Catherine Talbot reviews a recent qualitative study on accessing post-diagnostic dementia care before and since COVID-19, which highlights the need to reduce inequalities in dementia care.]
COVID-19: provision of immunisation sessions for outbreaks in schools.
Public Health England (PHE); 2021.
[Guidance for School Age Immunisation Services on the provision of immunisation sessions in schools where there are cases or an outbreak of COVID-19.]
UKHSA review into IPC guidance.
Department of Health and Social Care (DHSC); 2021.
[Recommendations for changes to COVID-19 infection prevention and control (IPC) advice to help ease pressure on the NHS.]
Impacts of the COVID-19 pandemic on youth mental health among youth with physical health challenges.[Abstract]
Hawke LD. Early Intervention in Psychiatry 2021;15(5):1146-1153.
[CONCLUSIONS: Mental health concerns are highly prevalent among youth with physical health concerns, and also appear to be exacerbated by the COVID-19 pandemic. Physical health concerns appear to constitute risk factors for heightened mental health responses to the pandemic situation. System planners striving to adapt mental health services to meet distancing recommendations are urged to consider youth with physical health conditions and ensure that integrated supports are available to them.]
NDNS: Diet and physical activity – a follow-up study during COVID-19.
Public Health England (PHE); 2021.
[This report presents the findings from a follow-up study of National Diet and Nutrition Survey Rolling Programme (NDNS RP) participants which aimed to describe and assess the impact of the COVID-19 pandemic on the diet and physical activity of people in the UK in 2020.]
Vaxzevria (AstraZeneca) Covid-19 vaccine: Recognition of batches manufactured in India.
House of Commons Library; 2021.
[This briefing provides an overview of the regulatory concerns associated with batches of the Vaxzevria (previously called AstraZeneca) vaccine which were manufactured in India.]
